Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

More articles from Guidelines to Practice

  • You have access
    Evaluation and management of gastroesophageal reflux disease: A brief look at the updated guidelines
    Priya Sasankan, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 700-703; DOI: https://doi.org/10.3949/ccjm.89a.22059

    Updated guidelines from the American College of Gastroenterology address the evaluation and management of reflux disease, consequences of long-term PPI therapy, and emerging therapies.

  • You have access
    Update on pneumococcal vaccination in adults: Simpler is better
    Craig D. Nielsen, MD, FACP, Joel A. Kammeyer, MD, MPH, FACP and Michael J. Tan, MD, FACP, FIDSA
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 640-642; DOI: https://doi.org/10.3949/ccjm.89a.22047

    Recommendations have been updated in the hopes not only of preventing more cases of invasive pneumococcal disease, but also of making the recommendations easier to follow.

  • You have access
    Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidance
    Glenn T. Werneburg, MD, PhD and Daniel D. Rhoads, MD
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 581-587; DOI: https://doi.org/10.3949/ccjm.89a.22008

    New guidance on ordering, processing, and reporting urine cultures focuses on reducing unnecessary antibiotic use and the misdiagnosis of urinary tract infection.

  • You have access
    Managing stage 1 hypertension: Consider the risks, stop the progression
    Abel Hooker, MD, Kevin G. Buda, DO and Maarya Pasha, MD
    Cleveland Clinic Journal of Medicine May 2022, 89 (5) 244-248; DOI: https://doi.org/10.3949/ccjm.89a.21101

    Guidelines on managing patients with stage 1 hypertension and a low 10-year risk of atherosclerotic cardiovascular disease.

  • You have access
    Anaphylaxis: Highlights from the practice parameter update
    Katherine N. Weller, MD and Fred H. Hsieh, MD
    Cleveland Clinic Journal of Medicine February 2022, 89 (2) 106-111; DOI: https://doi.org/10.3949/ccjm.89a.21076

    The update addresses diagnostic criteria, treatment options, prevention of recurrences, and patient education on avoiding triggers and using self-injectable epinephrine.

  • You have access
    Updated guidelines for immune thrombocytopenic purpura: Expanded management options
    Sherwin DeSouza, MD and Dana Angelini, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

    The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.

  • You have access
    Risk-based guidelines: Redefining management of abnormal cervical cancer screening results
    Amy Wiser, MD, FAAFP, Jeffrey D. Quinlan, MD, FAAFP and Pelin Batur, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 556-560; DOI: https://doi.org/10.3949/ccjm.88a.20193

    A shift from results-based to risk-based management, based on the patient’s immediate and 5-year risks of grade 3 or higher cervical intraepithelial neoplasia.

  • You have access
    Outpatient management of asthma in adults: A snapshot of the 2020 GINA report
    Kavya Kommaraju, MD and Mani Latifi, MD
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 377-380; DOI: https://doi.org/10.3949/ccjm.88a.20167

    A review of the guidelines, with a focus on what’s new and clinically important.

  • You have access
    Reversal of direct oral anticoagulants: Highlights from the Anticoagulation Forum guideline
    Haeshik S. Gorr, MD, Lucy Yun Lu, PharmD, MS and Eric Hung, PharmD, CACP, AE-C
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 98-103; DOI: https://doi.org/10.3949/ccjm.88a.19133

    Clear instructions on how to manage DOAC-associated bleeding.

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire